News

Wall Street Analysts Adjust ON Semiconductor Earnings Projections

Wall Street Analysts Adjust ON Semiconductor Earnings Projections

Analysts Update ON Semiconductor Earnings Forecasts

ON Semiconductor Corporation (NASDAQ: ON) is set to unveil its third-quarter earnings. As anticipation builds, analysts are revising their expectations for the company's performance. The latest reports suggest ON Semiconductor might report earnings of 97 cents per share, a decrease from $1.39 per share in the same quarter last year. This reflects the ongoing challenges the company faces amid fluctuating market conditions.

What to Expect in Revenue Reports

The projected revenue for the quarter is estimated at $1.75 billion, showing a decline from $2.18 billion recorded a year prior. These figures underline the shifts within the semiconductor market and the impacts of global economic trends. Investors and market watchers are keenly observing these indicators for insights into ON Semiconductor's future growth trajectory.

Recent Performance and Market Reactions

Recently, ON Semiconductor demonstrated a robust performance in its second quarter, surpassing analyst expectations and prompting a positive market reaction. Following the announcement of their financial results, shares increased by 1.7%, closing at $71.25, reflecting investor confidence. Such movements are crucial for potential buyers looking at the semiconductor sector very closely.

Analyst Ratings and Adjustments

Various seasoned analysts have provided their insights and ratings for ON Semiconductor, further shaping market expectations:

  • John Vinh from Keybanc maintained an Overweight rating, adjusting the price target from $95 to $90 as of early October, with a notable accuracy rate of 76%.
  • Vivek Arya of B of A Securities affirmed a Buy rating, increasing the price target from $80 to $90 after the second quarter results were announced. His accuracy stands impressively at 82%.
  • Deutsche Bank's Ross Seymore also reaffirmed a Buy rating, modifying the price target from $85 to $90, reflecting a strong confidence in ON Semiconductor's direction.
  • Conversely, Kevin Cassidy from Rosenblatt maintained a Neutral rating while revising the price target upward from $70 to $75, demonstrating cautious optimism.
  • Truist Securities' William Stein raised his price target from $85 to $97 while keeping a Buy rating, showing substantial faith in the company's potential for growth.

Evaluating Your Investment Choices

If you're contemplating an investment in ON Semiconductor, these analyst opinions provide clarity on the stock's potential. Each rating encapsulates the varying perspectives on the company’s future in a changing economic landscape. Given the current climate, it's essential to assess these insights while making informed decisions.

Frequently Asked Questions

1. What are analysts expecting for ON Semiconductor's Q3 earnings?

Analysts predict that ON Semiconductor will report earnings at 97 cents per share, down from $1.39 per share in the previous year.

2. What is the projected revenue for ON Semiconductor for the upcoming quarter?

The expected revenue is $1.75 billion, compared to $2.18 billion in the same quarter last year.

3. How have ON Semiconductor's stocks performed recently?

ON Semiconductor's shares increased by 1.7% recently, closing at $71.25 after reporting better-than-expected second-quarter results.

4. Which analysts have provided ratings for ON Semiconductor?

Analysts including John Vinh, Vivek Arya, Ross Seymore, Kevin Cassidy, and William Stein have provided updated ratings and price targets for ON Semiconductor.

5. Should I invest in ON Semiconductor based on analyst ratings?

While analyst ratings can offer guidance, it’s vital to conduct thorough research and consider your investment strategy before making any decisions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading

Top 5 Most Recently Viewed Articles

Caribou Biosciences Faces Class Action Lawsuit for Investor Losses

Updated Category News Views 100

Caribou Biosciences Faces Legal Challenges Caribou Biosciences, Inc. (NASDAQ: CRBU) is currently embroiled in a class action lawsuit filed by investors who claim to have suffered significant losses due to alleged securities fraud. The lawsuit centers around actions that occurred between specific dates when investors were misled regarding key aspects of the company’s...

Continue Reading
HSBC Continental Europe's 2025 Interim Report Highlights

Updated Category News Views 322

HSBC Continental Europe's 2025 Interim Report Overview Recently, HSBC Continental Europe reported its financial results for the first half of 2025, showcasing significant strides in performance across various business segments. The Board of Directors approved the consolidated financial statements, marking a crucial step in the bank's strategic direction. Financial...

Continue Reading
AmpliTech Group Secures $78 Million in 5G Radio Orders

Updated Category News Views 146

AmpliTech Group Announces Major LOI for 5G Radios AmpliTech Group, Inc. is making headlines with a significant development in its operations. The company, known for its innovative signal processing components aimed at satellite communications and both public and private 5G networks, has entered into a letter of intent (LOI) to secure an impressive $78 million in purchase...

Continue Reading
Elimini and HOFOR Collaborate on Groundbreaking CO2 Capture Project

Updated Category News Views 274

Innovative Collaboration for Carbon Removal Elimini, a leading expert in carbon removal, has formed a strategic partnership with HOFOR to explore the development of a large-scale bioenergy with carbon capture and storage (BECCS) facility. This ambitious collaboration is aimed at transforming the existing power generation processes into a sustainable solution that helps...

Continue Reading
Newbury Street Corp Gains Extra Time for Business Merger

Updated Category News Views 240

Newbury Street Acquisition Corp (NASDAQ: NBST) pulled the lever on a merger deadline extension back in 2024, giving itself an extra six months to close a potential business combination. This move wasn’t just some casual handwave; it came after a strong showing at a special meeting where shareholders cast 3,951,174 votes in favor of the extension—without a single...

Continue Reading